...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial
【24h】

Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial

机译:口服脂质体铁与静脉内铁治疗CKD患者缺铁性贫血的效果:一项随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Iron deficiency is a common cause of anaemia in non-dialysis chronic kidney disease (ND-CKD). Controversies exist about the optimal route of administration for iron therapy. Liposomal iron, a new generation oral iron with high gastrointestinal absorption and bioavailability and a low incidence of side effects, seems to be a promising new strategy of iron replacement. Therefore, we conducted a study to determine whether liposomal iron, compared with intravenous (IV) iron, improves anaemia in ND-CKD patients.
机译:铁缺乏症是非透析慢性肾脏病(ND-CKD)贫血的常见原因。关于铁疗法的最佳给药途径存在争议。脂质体铁是一种具有高胃肠道吸收和生物利用度且副作用少的新一代口服铁,似乎是一种有前景的铁替代新策略。因此,我们进行了一项研究,以确定脂质体铁与静脉内(IV)铁相比是否能改善ND-CKD患者的贫血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号